INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments
INMUNE BIO INC. (INMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments · last filed 2026-03-30
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2025 was $0.00.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2024 was $0.00.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2023 was $0.00.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2022 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $0.00 10-K · filed 2025-03-27 | |||
| 2024-04-30 | $0.00 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 | |||
| 2021-09-30 | $0.00 10-K · filed 2022-03-03 | $0.00 10-Q · filed 2021-11-03 | ||
| 2021-08-31 | $0.00 10-Q · filed 2021-11-03 | |||
| 2021-07-31 | $0.00 10-Q · filed 2021-11-03 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 10-Q · filed 2021-08-04 | ||
| 2021-01-31 | $0.00 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |